Taiho Pharmaceutical Co., Ltd. v. MSN Laboratories Private Ltd.

Taiho Pharmaceutical Co., Ltd. v. MSN Laboratories Private Ltd. The Federal Circuit dismissed the appeal and cross-appeal following the parties' joint stipulation of voluntary dismissal under Federal Rule of Appellate Procedure 42(b), with each side bearing its own costs. The order does not reach the merits. The order resolves the appeals without any merits ruling, so it gives no guidance on the underlying dispute, and the district court's judgment stands as the parties left it. Appeals dismissed. The appeal (2025-1407) and cross-appeal (2025-1453) came from the District of Delaware, No. 1:19-cv-02342-JLH, Judge Jennifer L. Hall. The parties filed a joint stipulation to voluntarily dismiss both appeals with prejudice under Fed. R. App. P. 42(b), each side bearing its own costs. The court noted that it generally does not specify whether a dismissal is with or without prejudice. The court ordered the appeals dismissed, with each side bearing its own costs, and issued the order as the mandate on April 28, 2026. The order does not describe the patents, technology, claims, or issues in the underlying case, so nothing about the merits can be drawn from it. Hatch-Waxman / ANDA remand non-precedential